SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

16 Nov 2010 07:00

RNS Number : 2224W
CVS Group plc
16 November 2010
Β 

ο»Ώ

Tuesday 16th November 2010

CVS Group plc ("CVS" or the "Company")

Acquisition

CVS Group plc

Β 

Β 

Acquisition of St David's Veterinary Hospital

Β 

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of St David's Veterinary Hospital (SDVH). SDVH is the centre of the small animal part of the St David's Veterinary group, one of the longest established and largest veterinary groups in the UK. It split into different speciality groups many years ago and the Small Animal Hospital is renowned throughout the South West as a leading centre for orthopaedic surgery. Peter Attenburrow will remain in charge of the business and will concentrate on his orthopaedic skills, with CVS providing full managerial support. This should result in improved capacity and services to the many referring practices that send cases to St David's for treatment.

The acquisition brings the total number of surgeries acquired to date in 2010 to 45 including a laboratory and a referral centre.

In total the group now operates 214 surgeries, 6 diagnostic labs, 1 pet crematorium and an online dispensary across the UK and remains the largest operator in a highly fragmented market.

The acquisition of SDVH is deemed to be a substantial transaction under the AIM Rules.

In the year ended 31 July 2009, SDVH achieved profit before tax of approximately Β£430,000 on turnover of approximately Β£1,858,000. The Company is acquiring the trade and assets of both St David's Veterinary Group and St David's Veterinary Clinic Limited and includes fixed assets of approximately Β£122,000 as at 31 July 2009. The consideration for the acquisition is Β£1,900,000 which includes Β£300,000 of deferred consideration but excludes payment in respect of stock and is being met entirely from existing cash resources. The practice employs 7 professional vets and 28 staff in total.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: "SDVH is a long established business and we are delighted to be continuing to add to our portfolio following our acquisitions earlier in the year. We look forward to working with the team at St David's to help continue the high level of animal care and customer service that they have been delivering to date."

For further enquiries please contact:

Β 

CVS Group plc

Β 

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Β 

Β 

Brewin Dolphin

Β 

Matt Davis

0845 213 1000

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQLLFEDLTLELII
Date   Source Headline
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20264:31 pmRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20269:34 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.